Insider track record
No signal scores available.
Kaplan Carl E: trading record in brief
Kaplan Carl E discloses dealings in Savient Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 30 December 2005 to 31 March 2006, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 4 April 2006, reports a share grant of €3,093 in Savient Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kaplan Carl E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
No declarations found
0 of 0 declarations
